This webcast will discuss Advances in Liver Disease. Viewers should expect to understand the scope of steatotic liver disease and the increasing burden on the current healthcare system. The program will discuss management of steatotic liver disease including novel pharmacologic treatment options; discuss new first line systemic therapy options for patients with unresectable hepatocellular carcinoma; introduce the changing landscape of hepatocellular carcinoma management including combination therapy, novel biomarkers, and the role of liver transplantation; and discuss recent advances in autoimmune hepatitis and a potential new first line therapy option.
Credit & MOC Details
Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.
Credit types
MOC types
FDA REMS
Qualifies for MIPS
Target Specialties
Pricing
All courses included · $25
Courses are included in to obtain credit viewers must pay $25 to access the posttest if they are not a member of one of our subscribing hospitals or affiliated with OSU or OSUWMC; some are also sold individually.
Collected from the provider’s public pages · source
Specialties served/covered
- Adolescent Medicine
- Advanced Heart Failure & Transplant Cardiology
- Cardiovascular Disease
- Clinical Cardiac Electrophysiology
- Critical Care Medicine
- Diagnostic Radiology
- Endocrinology, Diabetes & Metabolism
- Gastroenterology
- General Internal Medicine
- Geriatric Medicine
- Hematology
- Hospice & Palliative Medicine
- Interventional Cardiology
- Medical Oncology
- Nephrology
- Neurocritical Care
- Nuclear Medicine
- Pulmonary Disease
- Rheumatology
- Sleep Medicine
- Transplant Hepatology
- Cardio-Vascular
- Emergency & Critical Care
- GI & Liver
- Infectious Disease
- Internal Medicine
- Medical Subspecialties
- Oncology & Hematology
- Pain & Palliative
- Primary care
- Radiology
- No reviews yet. Be the first to share yours.



